بيرسون فيو صيدله - Free Online Quiz Maker

بيرسون فيو صيدله

Q1 Score: 1

a-Good Manufactor Protocol

b-Good Manu factor Product

c-General Manufactor Protocol

d-General Manufactor Product

Q2 Score: 1

a-not effective against G+ve cocci

b- has amino glycoside antibiotic

c-decrease GIT motility

e-should be used in pregnant woman if need

Q3 Score: 1

a-Bone marrow depression

b-Alopecia

c-Nausea and vomiting

e-Drive sex gland

Q4 Score: 1

a-gold preparations

b-hydroxychloroquine

c-methotrexate d- a and b

e- a , b and c

Q5 Score: 1

a- use another one is suitable

b- add another to increase it is activity

c- use tow or more preservative may increase the activity and may become suitable

d- a+c

Q6 Score: 1

a- Meropenem

b- Bacitracin

c- Amoxicillin

d- penicillin V

Q7 Score: 1

a- 3.33

b- 0.15

c- 1.60 d-3.00 x 10 -4 e-1.6x10 -4 Morality=mole/volume (L) Mole=molecular weight of subs. In 1 grams So, molecular weight of NACL=23+34=57 So, Mole=17.52/57=0.307 So, Morality=0.307/2=0.153

Q8 Score: 1

a- mannitol

b- dextrose

5% c- insulin

d- Suspension

Q9 Score: 1

a-reduce the reflex tachycardia

b-prevent the accumulation of hydralazine

c-prevent systemic lupus ( SLE ) due to hydralazine

d-prevent oedemae-increase

Q10 Score: 1

a-hydrophilicity

b-miscibility

c-immiscibility

d-solubility equilibrium

Q11 Score: 1

a- controlled studies fail to demonstrate a risk to the fetus in the trimester and there is no evidence of risk in later trimeste

b- fetal risk NOT demonstrated in animal studies but there are no controlled studies in pregnant women or animal reproduction studies have shown an adverse effect that was NOT confirmed in controlled studies in women during trimester

c-either animal study have revealed adverse effect on the fetus and there are no controlled human studies or studies in animal and women are not available

d- There is positive evidence of human fetal risk but the benefits of use in pregnant woman may be acceptable despite the risk

Q12 Score: 1

a-they have lower risk gastric adverse reactions

b-good evidence about their effectiveness

c-cardiac toxicity is a recent concern of this class

e-combination with non selective agents give more effective action

Q13 Score: 1

a- a.c.

b- a.a.

c- p.c.

d- q.i.d.

Q14 Score: 1

a-it is given to treat surgery associated infections

b-it is given to reduce the possibility of surgical site infection

c-should always be given regardless type of surgery

d-should be continued for 7 days after surgery

Q15 Score: 1

a- decrease rate of phase 0 depolarization

b- increase phase 3 repolarization

d- adrenergic receptor blocking

c- suppress phase 4 depolarization d- adrenergic receptor blocking

Q16 Score: 1

a-lethergy & fatigue

b-skin rash & headache

c-throbbing headache & dizziness

d-fluid retention hypotension

Q17 Score: 1

a-fast I.V. injection

b-slow I.V. injection

c-I.M. injection

d-IP(intraperitoneal) injection

Q18 Score: 1

a-in refrigerator

b-in freezing

c-at 10-20 c*

d-A&C

Q19 Score: 1

a-oral

b-S.C.

c-I.V

d-I.M.

Q20 Score: 1

a-WBC count with differential

b-oral glucose tolerance test

c- HBA1c

e- b and c

Q21 Score: 1

a- mannitol

b- dextrose

5% c- insulin

d- Suspension

Q22 Score: 1

a-acne

b- psoriasis

c- myocardial infarction

Q23 Score: 1

a-analgesic

b-hypnotic

c-diuretic

d-antihistaminic

Q24 Score: 1

a-gastric ulcer

b-uncontrolled hypotension

c-severe asthma

e-hypertension

Q25 Score: 1

a-labitolol

b-terazosine

c-cloridine

d-captopril

Q26 Score: 1

a-Na valproate

b-phenytoin

c-lithium

d-quinidine

Q27 Score: 1

a-thermodynamically stable

b-composed of two or more component that exist in one phase

c-homogenous

d-the solvent and solute can be separated by filtration

Q28 Score: 1

a- a.c.

b- a.a.

c- p.c.

d- i.c.

Q29 Score: 1

a-peripheral vasodilator

b-Hypertension

c-Cough suppressant Indications

Q30 Score: 1

a-reduce onset of complications

b-control symptoms of diabetes

d- a and b

e- a , b and c

Q31 Score: 1

a-gournal of pharmacy practice

b-applied therapeutic & clinical use of drug

c-new England Journal of medicine

d-Loncet

Q32 Score: 1

a- Increase hydrostatic pressure

b- Decrease oncotic pressure

c-capillary permeability

d- a and b e- a , b and

Q33 Score: 1

a-2 ppm

b-0.002 ppm

c-0.000002 ppm

Q34 Score: 1

a-glitazones are ineffective as mono therapy

b-GIT disturbance are common side effects of glycosidase inhibitors-a

c-start with small dose of oral agent and triturate up to 1-2 weeks

d-life style modification should not be enforced if an oral agent to be started

Q35 Score: 1

a-magnesium

b-chloride

c-bicarbonates

d-potassium

Q36 Score: 1

a- excretion in kidney decrease

b- decrease in liver enzymes function

c- reabsorption is high

e- A ,b

Q37 Score: 1

a-postural hypotension

b-hallucinations

c-anaphylactic shock

e-acute adrenergic crisis including sever hypertention

Q38 Score: 1

a- not effective against G +ve cocci

b- not macrolide antibiotic

c- can increase GIT motility

d-can not used in pregnant women if needed

Q39 Score: 1

a-endotoxin

b-exotoxin

c-antibiotics

d-cytotoxin

Q40 Score: 1

a--ve inotropic

b-+ve inotropic

c-Hypertension

d-Tachycardia

Q41 Score: 1

a-poliomyelitis

b-rabies

c-chicken pox

e-all of the above

Q42 Score: 1

a-facial flushing

b-dyspnea

c-marked tachycardia

d- a and b

Q43 Score: 1

a-Age

b-Sex

c-Both

d-Disease state

Q44 Score: 1

a- oxytocin

b- growth hormone

c-adrenocorticosteroid hormone

Q45 Score: 1

a- a.c.

b- o.n.

c- p.c. d

d- i.c.

Q46 Score: 1

a- chemical stability

b- PH

c-protein binding

d- A&B

Q47 Score: 1

a-penicillin V

b-penicillin G

c-floxapen

d-ampicillin

Q48 Score: 1

a-minimal exercise

b-low calcium intake

c-male gender

d-family history

Q49 Score: 1

a- AV node

b- SA node

c-pukinje fiber

d-internodal pathways

Q50 Score: 1

a-analgesic agent

b-uricosuric agent

c-antiinflamatory agent

e-agent which increases renal tubular reabsorption

Q51 Score: 1

a-alendronate should be taken 60 min. before breakfast

b-Ca and vit. D are essential

c-hormone replacement therapy should be considered

d-outcome should be assessed with periodic bone density

Q52 Score: 1

a- MERCK Index

b-handbook on injectable drugs

c-micromedix

d- a and b e- b and c

Q53 Score: 1

a-Film coat

b-Enteric coat

c-Grinding of tablet

Q54 Score: 1

a- avoid aspirin containing prepration

b-avoid doubling dose from herself

c-balanced food with green leaves to avoid thrombosis

d-if she pregnant, monitor INR to avoid DVT

Q55 Score: 1

a-capillary constriction

b-elevation of blood pressure

c-stimulation of gastric secretion

d-skeletal muscle paralysis e-slowing the heart rate

Q56 Score: 1

a-shake the bottle before use

b-suspension

c-freezing of drug

Q57 Score: 1

a- $Serotonin reuptake

b- dopamine agonist

c- Decrease dopamine in peripheral vessel

d- Dopamine antagonist e- 5HT1 antagonist

Q58 Score: 1

a-ACEIs such as lisinopril improves left ventricular function and reduces mortality -blocker such as carvidailol may have beneficialb

b- effect in selected patient

c-spironolactone should be avoided because of the great risk of hypokalemia

d-non drug therapy includes appropriate fluid and dietary sodium-restriction

Q59 Score: 1

a-inotropy

b-chronotropy

c-automaticity

d-contractility

Q60 Score: 1

a-muscarinic antagonist

b-muscarinic agonist

c-nicotinic antagonist

d-nicotinic agonist

Q61 Score: 1

a- first pass

b- drug metabolism

c- drug distribution

Q62 Score: 1

a-Eye preparption

b-Parentral preparation

c-Solution

e-External preparation

Q63 Score: 1

A-cataract

b-hypoglycemia

c-skeletal muscle weakness

d-sodium retention

Q64 Score: 1

a-symptomatic control of seizures with benzodiazepine

b-activated charcoal to enhance elimination

c- b blocker for tachycardia

e-methylphenidate to reduce excessive sedation

Q65 Score: 1

a-naloxone

b-bethidine

c-morphine

d-celecoxib

Q66 Score: 1

a-Half life

b-Excreted hepatically

d-Excreted unchanged in urine

Q67 Score: 1

a-ibuprofen

b- aspirin

c- naprosyn

d- sevredol

Q68 Score: 1

a-ventricular arrythmias

b-atrial bradycardia

c-supraventricular tachycardia

d-supraventricular bradycardia

Q69 Score: 1

a-analgesic

b-verapamil

c-aspirin

d-diphenhydramine

Q70 Score: 1

a-slow ventricular response using verapamil

b-start lidocaine infusion

c- considered anticoagulation with warfarine

d- a and b

Q71 Score: 1

a-salbutamol

b-diphenhydramine

c-acetazolamide

d-epinephrine

Q72 Score: 1

a-is effective against G +ve Cocci

b-is a macrolide antibiotic

c-can increase g.i.t. motility

e-all of the above

Q73 Score: 1

a-50000 ( nanogrames )?

b- 0.05 ( milligrams )?

c- 0.0005 g

d- a and b

Q74 Score: 1

a- age

b- sex

c- dosage form

d- Drug state e- A and B

Q75 Score: 1

a- 3: 1 90% 30

b-1:3 80%

c-10:30 50% 10

d- 5: 9

Q76 Score: 1

a-glyburinid

b-insulin

c-metformin

d-nateglinid

Q77 Score: 1

a-associated hypokalemia could be avoided by giving K-supplement

b-effective in reducing proteinurea in diabetic patient

c-most common side effect is chronic dry cough

d-a good first line treatment for hypertensive diabetic

Q78 Score: 1

a-take this medication with food or milk

b-avoid multivitamine preparations during treatment

c-avoid taking paracetamol during treatment

e-this medication may cause discolouration of urine

Q79 Score: 1

a- 1-5 mg b- 15-60 mg

c- 300-600

d -should be continued for 7 days after surgery

e-all are true

Q80 Score: 1

a-mast cell stabilization

b-bronchodilator

c-prostaglandins modifier

d-leukotrienes modifier e-non of the above

Q81 Score: 1

a-combination of drugs always preferred

b-hydralazine is first line therapy in young hypertension

c-furosemide should be administrated before meal to improve absorption

d-beta-blokers should be avoided in asthmatic patient

Q82 Score: 1

a-impaired fat absorption

b-pulmonary emboli

c-tuberculosis

d-neoplastic disorders

Q83 Score: 1

a-Diazepam

b-Estazolam

c-Triazolam

d-Temazepam

Q84 Score: 1

a-verify time of last time

b-check Mg and K levels and correct if needed

c-monitor ECG

d-no antidote for digoxin

Q85 Score: 1

a-Tissue solubility

b-Protein binding

c-Molecular weight of drug

d-Type enzyme response of metabolism

Q86 Score: 1

a-Carrier of drug

b-Emollient

c-A&B

d-Increase absorption

Q87 Score: 1

a-primaquine

b-quinine

c-chloroguanide

Q88 Score: 1

a-allopurinol

b-indomethacin

c-colchicine

d-probencid

Q89 Score: 1

a-25%

b-60%

c-80%

d-10%

Q90 Score: 1

a- O2 removal

b- O2 retention

c- CO2 removal

d- CO2 retention

Q91 Score: 1

a-airway control

b-IV of crystalloid solution

c-dopamine to support blood pressure

e-all of the above

Q92 Score: 1

a-initial dose 0.6 u / kg / day split 2/3 a.m and 1/3 p.m

b-regular NPH ratio is 1 : 1 or 1 : 2

c-dose may need to be increased during acute illness

a , b and c

Q93 Score: 1

a- captopril

b- cimetidine

c- metoformin

Q94 Score: 1

a-hyperperfusion

b-hypoperfusion

c-tachycardia

d-bradycardia

Q95 Score: 1

a-Inhibitors of cell membrane function

b-inhibitors nucleic acid synthesis

c-Inhibitors of protein synthesis

d-Inhibitors of cell wall synthesis

Q96 Score: 1

a-albumin 5%

b-ringer`s solution

c-dextran

d-beta starch

Q97 Score: 1

a-12ml of MGCL dissolve in 100 ml water

b-12 mg of MGCL dissolve in 100 ml water

c-12ml of MGCL dissolve in 1000 ml water

d-90.5 ml of MGCL dissolve in 100 ml water

Q98 Score: 1

+a- K

+b- Na

c- Ca

d- CO3

Q99 Score: 1

a-similar in action to ergotamine

b-similar in action to tubocurarine

c-used as an antihistamine

d-pure b -adrenergic receptor blocker

Q100 Score: 1

a-IL-1 blocker

b-used for treatment of severe rheumatoid arthritis

c-may increase risk of infections

d-administered as IV infusion

Questions you haven't answered yet:

Are you sure you want to end this test and send your answers?

About Us | Terms Of Use | Privacy Policy